HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio E Kater Selected Research

2-toluenesulfonamide (OTS)

1/2021Novel Markers of Recovery From Overtraining Syndrome: The EROS-LONGITUDINAL Study.
1/2021Effects of Overtraining Status on the Cortisol Awakening Response-Endocrine and Metabolic Responses on Overtraining Syndrome (EROS-CAR).
8/2019Basal Hormones and Biochemical Markers as Predictors of Overtraining Syndrome in Male Athletes: The EROS-BASAL Study.
6/2019Clinical and biochemical characteristics of high-intensity functional training (HIFT) and overtraining syndrome: findings from the EROS study (The EROS-HIFT).
1/2019Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS study.
1/2019Inter-correlations Among Clinical, Metabolic, and Biochemical Parameters and Their Predictive Value in Healthy and Overtrained Male Athletes: The EROS-CORRELATIONS Study.
8/2018Body composition, metabolism, sleep, psychological and eating patterns of overtraining syndrome: Results of the EROS study (EROS-PROFILE).
7/2018Hormonal response to a non-exercise stress test in athletes with overtraining syndrome: results from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) - EROS-STRESS.
12/2017Hypothalamic-Pituitary-Adrenal (HPA) Axis Functioning in Overtraining Syndrome: Findings from Endocrine and Metabolic Responses on Overtraining Syndrome (EROS)-EROS-HPA Axis.
1/2017Hormonal aspects of overtraining syndrome: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudio E Kater Research Topics

Disease

10Overtraining Syndrome
01/2021 - 01/2017
7Fatigue
08/2019 - 08/2016
6Hypertension (High Blood Pressure)
03/2022 - 01/2004
5Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
03/2022 - 10/2004
5Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
02/2018 - 05/2003
4Adrenal incidentaloma
01/2021 - 07/2018
4Cushing Syndrome
01/2021 - 11/2007
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 04/2006
3Hypokalemia
03/2019 - 01/2004
3Adenoma (Adenomas)
03/2019 - 10/2004
2Virilism (Virilization)
03/2022 - 09/2017
2Hypogonadism (Hypergonadotropic Hypogonadism)
02/2018 - 11/2010
2Disorders of Sex Development (Intersexuality)
05/2008 - 01/2004
2Insulin Resistance
11/2007 - 04/2006
1Antley-Bixler Syndrome Phenotype
03/2022
1Familial Hyperaldosteronism
03/2022
1Sleep Deprivation
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Pituitary Neoplasms (Pituitary Adenoma)
03/2019
1Ectopic ACTH Syndrome
03/2019
1Hyperglycemia
03/2019
1Pituitary ACTH Hypersecretion
03/2019
1Dehydration (Water Stress)
08/2018
1Hypoglycemia (Reactive Hypoglycemia)
07/2018
1Sexual Infantilism
02/2018
1Amenorrhea
02/2018
1Leydig Cell Tumor
09/2017
1Breast Neoplasms (Breast Cancer)
09/2017
1Neoplasms (Cancer)
09/2017
1Chronic Renal Insufficiency
09/2017
1Infertility (Sterility)
03/2014
1Osteoporosis
03/2014
1Deafness (Deaf Mutism)
11/2012
1Obesity
11/2007
1Type 2 Diabetes Mellitus (MODY)
10/2007
1Overweight
10/2007
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
04/2006
1Hyperplasia
10/2004
1Addison Disease (Addison's Disease)
10/2004
1Hyperpigmentation
10/2004
1Hyperaldosteronism (Conn Syndrome)
10/2004
1Sleep Wake Disorders
10/2003
1Frailty
04/2002

Drug/Important Bio-Agent (IBA)

11Hydrocortisone (Cortisol)FDA LinkGeneric
03/2022 - 04/2002
102-toluenesulfonamide (OTS)IBA
01/2021 - 01/2017
5Adrenocorticotropic Hormone (ACTH)FDA Link
03/2022 - 12/2010
5SteroidsIBA
03/2022 - 05/2003
4AndrogensIBA
03/2022 - 03/2014
4Dexamethasone (Maxidex)FDA LinkGeneric
03/2022 - 03/2019
321-deoxycortisolIBA
12/2010 - 06/2006
2AldosteroneIBA
03/2022 - 10/2004
2EnzymesIBA
03/2022 - 02/2018
2Biomarkers (Surrogate Marker)IBA
08/2019 - 01/2019
2ProgesteroneFDA LinkGeneric
02/2018 - 09/2017
2Estrogens (Estrogen)FDA Link
02/2018 - 09/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2016 - 03/2014
2Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
11/2010 - 01/2004
2SaltsIBA
05/2008 - 10/2004
217-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA
05/2008 - 06/2006
2Cortodoxone (11 Deoxycortisol)IBA
05/2008 - 06/2006
2Insulin (Novolin)FDA Link
11/2007 - 04/2006
1AndrosteroneIBA
03/2022
1Coenzymes (Enzyme Cofactors)IBA
03/2022
1CortisoneFDA Link
03/2022
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
03/2022
1Dehydroepiandrosterone (DHEA)IBA
03/2022
1Oxidoreductases (Dehydrogenase)IBA
03/2022
1Dihydrotestosterone (Androstanolone)IBA
03/2022
1Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
03/2022
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
03/2022
1Hormones (Hormone)IBA
08/2019
1MineralocorticoidsIBA
02/2018
1Desoxycorticosterone (Deoxycorticosterone)IBA
02/2018
1GonadotropinsIBA
02/2018
1Estradiol (Delestrogen)FDA LinkGeneric
09/2017
1Androgen Receptors (Androgen Receptor)IBA
09/2017
1Aromatase InhibitorsIBA
09/2017
1Transfer RNA (tRNA)IBA
11/2012
1Leucine (L-Leucine)FDA Link
11/2012
1Mitochondrial DNA (mtDNA)IBA
11/2012
1Mixed Function Oxygenases (Monooxygenases)IBA
11/2010
1Androstenedione (4 Androstene 3,17 dione)IBA
05/2008
1CarbenoxoloneIBA
11/2007
1Blood Glucose (Blood Sugar)IBA
11/2007
111-beta-Hydroxysteroid Dehydrogenase Type 1IBA
11/2007
1Metformin (Glucophage)FDA LinkGeneric
04/2006
1Oral ContraceptivesIBA
04/2006
1ThiazolidinedionesIBA
04/2006
1AutoantibodiesIBA
10/2004
1ReninIBA
10/2004
1Prednisolone (Predate)FDA LinkGeneric
10/2004
1Steroid 21-Hydroxylase (21 Hydroxylase)IBA
10/2004
1PotassiumIBA
01/2004
1Protein SIBA
01/2004

Therapy/Procedure

3Therapeutics
08/2016 - 10/2004
1Radiofrequency Ablation
10/2016